Top Chinese security body calls for ‘crackdown’ after protests
The Communist Party’s top security body has called for a “crackdown” on “hostile forces” after China saw protests in major...
Month: November 2022
What Is the Genetic Influence on the Severity of COVID 19?
A striking characteristic of COVID‑19 is that the severity of clinical outcomes is remarkably variable. Establishing a prognosis for individuals...
Twitter stops policing Covid-19 misinformation under CEO Elon Musk and reportedly restores 62,000 suspended accounts
In this articleTWTRFollow your favorite stocksCREATE FREE ACCOUNTElon Musk's Twitter account displayed on a mobile with Elon Musk in the...
NH awaiting COVID-19 test results from local deer population
This story was originally produced by the Keene Sentinel. NHPR is republishing it in partnership with the Granite State News Collaborative.After COVID-19...
Remote workers reclaimed 60 million hours of commuting time and are prioritizing their wellbeing—not work
The shift to remote work during the Covid-19 pandemic gave Americans 60 million hours of their time back. And recent...
Can Paxlovid Treat the Symptoms of Long COVID?
Months after catching COVID-19 in December 2021, Lavanya Visvabharathy was still testing positive on antigen tests and suffering from symptoms...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HOB5BCNSBBL2LA7R2YNYI3O6UY.jpg "Britain summons China’s ambassador over treatment of BBC journalist")
Britain summons China’s ambassador over treatment of BBC journalist
LONDON, Nov 29 (Reuters) - Britain summoned China's ambassador on Tuesday to raise the treatment of a British journalist whose...
Twitter has stopped enforcing its COVID-19 misinformation policy
Twitter's long-running effort to fight COVID-19 misinformation is at an end, at least for now. As Twitter users and CNN...
Ukraine Is Biden’s Defining Issue, and His Biggest Economic Challenge
The shape of the war, and its effects on global markets, in the months and years to come could determine...
Blood Thinner Ineffective for COVID-19 Patients: Study
New data from a clinical trial suggest that apixaban, an anticoagulant that’s widely been prescribed to promote recovery in patients...